The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
4.5 roundtable meetings
Related to January 2014 Board Meeting, agenda item 4.5
Status of President’s Roundtables
The following invitation only roundtable events are scheduled to be held during the Congress:
Wednesday 26th March
1700-1815, Room 122: Update to stakeholders on the development of European Statements of Hospital Pharmacy
Involving Neal Maskrey, AB, DP and others.
To give an update to stakeholders on:
– why EAHP reviewed the 2008 Basel statements for Europe
– how the review has been conducted (e.g. Summit WG2, Delphi process)
– key changes proposed for the Summit
– how the Summit will operate.
The session will give a chance for stakeholders to give feedback and help Summit organisers to anticipate issues that may be raised at the event in May.
Recent discussion on the format of the roundtable with Neal Maskrey here, including the idea of having break-out groups.
Discussion required as to attendance and room logistics.
1930-2100, Room 128: The formation of a common training framework for hospital pharmacy specialisation
RP will update EAHP members on the progress made in enabling hospital pharmacy to form a common training framework, permitting cross border recognition of HP specialisation.
Referencing examples from other professional specialties (e.g. medical, dental and veterinary), an outline method for converging towards a jointly agreed set of competencies, and a prospective timetable for achieving this, will be provided for member discussion. Linda Horspool of the European Board of Veterinary Specialisation has agreed to give a short
Intended outcomes of the session include giving members a clearer sense of what is required of their participation in an HP CTF, and identifying the likely lead countries to help govern the long term project.
Preparation reading materials and other documents will be circulated to member associations in early March 2014 to assist their preparation for the session.
See also agenda item 10.1.
Thursday 27th March
[UPDATED FROM PREVIOUS GPI SUGGESTION] 0830-1000, Room 122: Member Association briefing on medicines shortages lobbying
Addressing the need to engage EAHP members to lobby at a national level for European action on medicines shortages, the session is intended as an opportunity to share information and proposed member activity in relation to:
– the European elections (ensuring candidates for election are aware of the issues before election)
– the period between May and November in which the next Commission is being formed
The intended outcome is to engage national governments to request the Commission take action on the shortages issue.
It will also be an opportunity to promote the proposed update survey of members on the current state of shortages in Europe, and the extent to which it is diverting energies from other patient-focused tasks.
See also materials under agenda item 10.3 for more information
1145-1300, Room 122: Measuring and implementing European Statements of Hospital Pharmacy
David Gerrett and David Cousins will provide updates to stakeholders on the results so far of their work researching respectively: the common challenges hospital pharmacists face when seeking to implement practice improvements; and the use of measurement tools by hospital pharmacists.
An opportunity will be provided for stakeholders to give their reflections on the shared results and comment on any next stages of the work.
Potential space to also discuss how EAHP future survey activity is intended to more explicitly benchmark/measure implementation of the European statements on hospital pharmacy.
See also agenda items 9.1 Survey update and 9.5.2 GPIs, metrics and implemention